PT - JOURNAL ARTICLE AU - Alexa Torrens AU - Valentina Vozella AU - Hannah Huff AU - Brandon McNeil AU - Faizy Ahmed AU - Andrea Ghidini AU - Stephen V Mahler AU - Marilyn A Huestis AU - Aditi Das AU - Daniele Piomelli TI - Comparative Pharmacokinetics of Δ<sup>9</sup>-Tetrahydrocannabinol in Adolescent and Adult Male Mice AID - 10.1124/jpet.120.265892 DP - 2020 Jan 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - jpet.120.265892 4099 - http://jpet.aspetjournals.org/content/early/2020/04/28/jpet.120.265892.short 4100 - http://jpet.aspetjournals.org/content/early/2020/04/28/jpet.120.265892.full AB - We investigated the pharmacokinetic properties of Δ9-tetrahydrocannabinol (Δ9-THC), the main psychoactive constituent of cannabis, in adolescent and adult male mice. The drug was administered at logarithmically ascending doses (0.5, 1.6 and 5 mg/kg, intraperitoneal) to pubertal adolescent (37-day old) and adult (70-day old) mice. Δ9-THC and its first-pass metabolites - 11-hydroxy-Δ9-THC (11-OH-THC) and 11-nor-9-carboxy-Δ9-THC (11-COOH-THC) - were quantified in plasma, brain and white adipose tissue (WAT) using a validated isotope-dilution liquid chromatography/tandem mass spectrometry assay. Δ9-THC administration (5 mg/kg) reached 50% higher circulating concentration in adolescent than in adult mice. A similar age-dependent difference was observed in WAT. Conversely, 40% to 60% lower brain concentrations and brain-to-plasma ratios for Δ9-THC and 50% to 70% higher brain concentrations for Δ9-THC metabolites were measured in adolescent relative to adult animals. Liver microsomes from adolescent mice converted Δ9-THC into 11-COOH-THC twice as fast as adult microsomes. Moreover, the brain of adolescent mice contained higher mRNA levels of the multi-drug transporter Abcg2, which may extrude Δ9-THC from the brain, and of claudin-5, a protein that contributes to blood-brain barrier integrity. The results reveal the existence of multiple dissimilarities in the distribution and metabolism of Δ9-THC between adolescent and adult male mice, which might influence wide-ranging pharmacological responses to the drug.SIGNIFICANCE STATEMENT Animal studies suggest that adolescent exposure to Δ9-tetrahydrocannabinol, the intoxicating constituent of cannabis, causes persistent changes in brain function. These studies generally overlooked the impact that age-dependent changes in the distribution and metabolism of the drug might exert on its pharmacological effects. This report provides a comparative analysis of the pharmacokinetic properties of Δ9-THC in adolescent and adult male mice, and outlines multiple functionally significant dissimilarities in the distribution and metabolism of Δ9-THC between these two age groups.